Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma

Raphaella Lambert; Scott Stratman; Grace Rabinowitz; Hannah Verma; Jonas A. Adalsteinsson; George Niedt; Benjamin Ungar; Nicholas Gulati

doi:10.1016/j.jdcr.2024.12.030

Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma

Raphaella Lambert
, Scott Stratman
, Grace Rabinowitz
, Hannah Verma
, Jonas A. Adalsteinsson
, George Niedt
, Benjamin Ungar
, Nicholas Gulati

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	118-120
Number of pages	3
Journal	JAAD Case Reports
Volume	58
DOIs	https://doi.org/10.1016/j.jdcr.2024.12.030
State	Published - Apr 2025

Keywords

cutaneous immune-related adverse event
eczema
hepatocellular carcinoma
immune checkpoint inhibitor
tremelimumab

Access to Document

10.1016/j.jdcr.2024.12.030

Cite this

@article{f35519cc294f45f3a43ae98732c2b52b,

title = "Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma",

keywords = "cutaneous immune-related adverse event, eczema, hepatocellular carcinoma, immune checkpoint inhibitor, tremelimumab",

author = "Raphaella Lambert and Scott Stratman and Grace Rabinowitz and Hannah Verma and Adalsteinsson, \{Jonas A.\} and George Niedt and Benjamin Ungar and Nicholas Gulati",

year = "2025",

month = apr,

doi = "10.1016/j.jdcr.2024.12.030",

language = "English",

volume = "58",

pages = "118--120",

journal = "JAAD Case Reports",

issn = "2352-5126",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma

AU - Lambert, Raphaella

AU - Stratman, Scott

AU - Rabinowitz, Grace

AU - Verma, Hannah

AU - Adalsteinsson, Jonas A.

AU - Niedt, George

AU - Ungar, Benjamin

AU - Gulati, Nicholas

PY - 2025/4

Y1 - 2025/4

KW - cutaneous immune-related adverse event

KW - eczema

KW - hepatocellular carcinoma

KW - immune checkpoint inhibitor

KW - tremelimumab

UR - https://www.scopus.com/pages/publications/105001308266

U2 - 10.1016/j.jdcr.2024.12.030

DO - 10.1016/j.jdcr.2024.12.030

M3 - Article

AN - SCOPUS:105001308266

SN - 2352-5126

VL - 58

SP - 118

EP - 120

JO - JAAD Case Reports

JF - JAAD Case Reports

ER -